Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Oct 5;(10):CD003175. doi: 10.1002/14651858.CD003175.pub2

Comparison 7.

Subgroup analysis of NON-endometriod cancer (clear and serous)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Death from any cause (HR) for subgroup serous/clear cell 2 Hazard Ratio (Random, 95% CI) 0.98 [0.68, 1.40]
2 Death or recurrence (HR) for subgroup serous/clear cell cancer 2 Hazard Ratio (Random, 95% CI) 0.84 [0.57, 1.23]